Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01541358 · ClinicalTrials.gov registry record · NA
Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01541358: Clinical Trial NA study, sponsored by Stanford University.
NCT01541358 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01541358, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This clinical trial studies fluorine F-18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) in diagnosing bone tumors in patients with cancer. Diagnostic procedures, such as fluorine F-18 sodium fluoride PET/CT, may help find and diagnose bone cancer
Interventions
- PROCEDURE positron emission tomography/computed tomography
- RADIATION fluorine F 18 sodium fluoride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01541358
The ClinicalTrials.gov registry entry for NCT01541358 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which positron emission tomography/computed tomography is the first listed.
NCT01541358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01541358 about?
NCT01541358 is a clinical study titled "Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer". This clinical trial studies fluorine F-18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) in diagnosing bone tumors in patients with cancer. Diagnostic procedures, such as fluorine F-18 sodium fluoride PET/CT, may help find and diagnose bone cancer
What is the current status of trial NCT01541358?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2012-05. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01541358?
The interventions under investigation include: positron emission tomography/computed tomography (PROCEDURE), fluorine F 18 sodium fluoride (RADIATION).
Who is sponsoring clinical trial NCT01541358?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.